News und Analysen
![Trane Technologies to Present at the Barclays Industrial Select Conference: https://brand.tranetechnologies.com/content/dam/cs-corporate/brand-center/logo-black.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEl2Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--537711cc40b8f63228e8dfc29c760375e96a54ab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-black.png?locale=de)
Trane Technologies to Present at the Barclays Industrial Select Conference
Trane Technologies plc (NYSE: TT) a global climate innovator, announced today that company leadership will participate in a fireside chat at the Barclays Industrial Select Conference. They will
![NICE Provides Dial-in Details for its Fourth Quarter 2021 Results Teleconference: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtvRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--06f22a0c3a8fabdec4f231cf3ebdea0279feec53/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NICE_inContact.jpg?locale=de)
NICE Provides Dial-in Details for its Fourth Quarter 2021 Results Teleconference
NICE (Nasdaq: NICE) will announce its fourth quarter 2021 results on Thursday, February 17th, before the opening of the NASDAQ Stock Exchange
Later that day, management will host a conference call
![Trane Technologies to Present at Citi’s 2022 Global Industrial Tech and Mobility Conference: https://brand.tranetechnologies.com/content/dam/cs-corporate/brand-center/logo-black.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEl2Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--537711cc40b8f63228e8dfc29c760375e96a54ab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-black.png?locale=de)
Trane Technologies to Present at Citi’s 2022 Global Industrial Tech and Mobility Conference
Trane Technologies plc (NYSE: TT), a global climate innovator, announced today that company leadership will participate in a fireside chat at Citi’s 2022 Global Industrial Tech and Mobility
DGAP-News: Linde plc: Linde Reports Full-Year and Fourth-Quarter 2021 Results (Earnings Release Tables Attached)
![Transgene Appoints Steven Bloom as Chief Business Officer: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFo2Rmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--73fe07bc16ac0607e1cc0e1a0b34e650fa94b07d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo_TRANSGENE.jpg?locale=de)
Transgene Appoints Steven Bloom as Chief Business Officer
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced today that it has appointed
![Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTRsSXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3cb1084fef1621d4cc02d287c5adfbf3414ba268/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Createurs_de_Convivialite.jpg?locale=de)
Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn
Regulatory News:
Pernod Ricard (Paris:RI):
Press release - Paris, 10 February 2022
SALES
Sales for H1 FY22 totalled €5,959m, with an organic growth of +17% (+20% reported), with a
![Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTRsSXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3cb1084fef1621d4cc02d287c5adfbf3414ba268/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Createurs_de_Convivialite.jpg?locale=de)
Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn
Regulatory News:
Pernod Ricard (Paris:RI):
Press release - Paris, 10 February 2022
SALES
Sales for H1 FY22 totalled €5,959m, with an organic growth of +17% (+20% reported), with a
![DGAP-News: Delivery Hero exceeds 2021 GMV guidance and sets 2022 outlook to reach positive adjusted EBITDA for its platform business: https://www.deliveryhero.com/newsroom/downloads/](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2JrS1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dbefb41b633948a96b3d6366cb1b78d9e4f5f680/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Delivery-Hero-Logo-Red.png?locale=de)
DGAP-News: Delivery Hero exceeds 2021 GMV guidance and sets 2022 outlook to reach positive adjusted EBITDA for its platform business
![DGAP-News: Delivery Hero übertrifft GMV-Prognose für 2021 und erwartet für 2022 ein positives bereinigtes EBITDA des Plattformgeschäfts: https://www.deliveryhero.com/newsroom/downloads/](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2JrS1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dbefb41b633948a96b3d6366cb1b78d9e4f5f680/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Delivery-Hero-Logo-Red.png?locale=de)
DGAP-News: Delivery Hero übertrifft GMV-Prognose für 2021 und erwartet für 2022 ein positives bereinigtes EBITDA des Plattformgeschäfts
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle again reports strong performance in 2021
DGAP-News: Bechtle again reports strong performance in 2021
Gap Inc. to Report Fourth Quarter 2021 Results on March 3
Gap Inc. (NYSE: GPS) will report its fourth quarter 2021 earnings results by press release on March 3, 2022 at 1:15 p.m. Pacific Time.
In addition, the company will host a summary of Gap Inc.’s
![Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM25oRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fb25377a8ea9e69d3b62f03b482ed70fb95efba1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LOGO_NANO_EXPANDING_LIFE.jpg?locale=de)
Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
![IFF Reports Fourth Quarter and Full Year 2021 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24521/International_Flavors_and_Fragrances_%28logo%29.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ01CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--51f91475ae75e581820ddc30e3dc8db1ebc296be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/International_Flavors_and_Fragrances_-28logo-29.png?locale=de)
IFF Reports Fourth Quarter and Full Year 2021 Results
International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2021.
Fourth Quarter 2021 Consolidated Summary:
Reporte
![Intevac Announces Fourth Quarter and Full Year 2021 Financial Results: https://mms.businesswire.com/media/20191101005110/en/497226/5/IVAC_LOGO_Horizontal_.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGtqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db42b6df7d07d0fe0d3f25aae31922e20e7166a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IVAC_LOGO_Horizontal_.jpg?locale=de)
Intevac Announces Fourth Quarter and Full Year 2021 Financial Results
Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the fiscal fourth quarter and year ended January 1, 2022.
Fiscal 2021 Highlights
-
Completion of the sale of our Photonics
![IFF Appoints Barry A. Bruno to Board of Directors: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24521/International_Flavors_and_Fragrances_%28logo%29.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ01CIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--51f91475ae75e581820ddc30e3dc8db1ebc296be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/International_Flavors_and_Fragrances_-28logo-29.png?locale=de)
IFF Appoints Barry A. Bruno to Board of Directors
IFF (NYSE: IFF) today announced the appointment of Barry A. Bruno to the Company’s Board of Directors as an independent director, effective February 8, 2022.
“We are pleased to welcome Barry to
![Diodes Incorporated Reports Record Fourth Quarter and Fiscal 2021 Financial Results: https://mms.businesswire.com/media/20200323005671/en/218867/5/Diodes_logo_%28r%29_small.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK01wS3c9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6d1b3aa1b9ea7e46f1f47ed77fa795bafe6e3c66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Diodes_logo_-28r-29_small.jpg?locale=de)
Diodes Incorporated Reports Record Fourth Quarter and Fiscal 2021 Financial Results
Diodes Incorporated (DIODES™) (Nasdaq: DIOD) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2021.
Fourth Quarter and Recent Highlights
-
Revenue
![LiveRamp Announces Strong Third Quarter Results and Raises Full Year Outlook: https://mms.businesswire.com/media/20191105005799/en/754502/5/Source-Logo-300.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNUVsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--63037493ab9990bdff69777878a54794a007194d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Source-Logo-300.jpg?locale=de)
LiveRamp Announces Strong Third Quarter Results and Raises Full Year Outlook
LiveRamp® (NYSE: RAMP), the leading global data connectivity platform, today announced its financial results for the quarter ended December 31, 2021.
This press release features multimedia. View
![Blue Bird Reports Fiscal 2022 First Quarter Results;
Focused on Margin Expansion and EV Growth;
Impacted by Supply Chain Disruptions, Inflationary Pressures;
Confirms FY2022 Guidance: https://mms.businesswire.com/media/20210323005889/en/866918/5/Nuvve+%281%29+%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXBDVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c5b16db91a1bf6d6bfe6c63b355a012accefdc15/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nuvve+-281-29+-28002-29.jpg?locale=de)
Blue Bird Reports Fiscal 2022 First Quarter Results; Focused on Margin Expansion and EV Growth; Impacted by Supply Chain Disruptions, Inflationary Pressures; Confirms FY2022 Guidance
Blue Bird Corporation (“Blue Bird”) (Nasdaq: BLBD), the leader in electric and low-emission school buses, announced today its fiscal 2022 first quarter results. GAAP net loss for the quarter of
![Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2ZTRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b712c468526d55562ab49f3be62219307b94942b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/30686-44937-TMO_Magenta_1213.jpg?locale=de)
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE
2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and
![Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2ZTRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b712c468526d55562ab49f3be62219307b94942b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/30686-44937-TMO_Magenta_1213.jpg?locale=de)
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE
2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and
![Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2ZTRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b712c468526d55562ab49f3be62219307b94942b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/30686-44937-TMO_Magenta_1213.jpg?locale=de)
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE
2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and
![Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzNhTUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39aa1a81526ac2a70cd04ea71d1ab318c23b607c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EUROFINS_.jpg?locale=de)
Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam
Eurofins Scientific (“Eurofins”) (Paris:ERF), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces that its subsidiary, Eurofins Clinical Testing Lux